Risk management in therapeutics: when the patient becomes the last line of defense

dc.contributor.author	Gurwitz, Jerry H.
dc.contributor.author	Andrade, Susan E.
dc.date	2022-08-11T08:09:22.000
dc.date.accessioned	2022-08-23T16:28:01Z
dc.date.available	2022-08-23T16:28:01Z
dc.date.issued	2002-12-07
dc.date.submitted	2011-12-09
dc.identifier.citation	Pharmacoepidemiol Drug Saf. 2002 Dec;11(8):637-9. <a href="http://dx.doi.org/10.1002/pds.777">Link to article on publisher's site</a>
dc.identifier.issn	1053-8569 (Linking)
dc.identifier.doi	10.1002/pds.777
dc.identifier.pmid	12512236
dc.identifier.uri	http://hdl.handle.net/20.500.14038/36921
dc.language.iso	en_US
dc.relation	<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=12512236&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.url	http://dx.doi.org/10.1002/pds.777
dc.subject	Humans
dc.subject	*Risk Management
dc.subject	Therapeutics
dc.subject	Health Services Research
dc.subject	Primary Care
dc.title	Risk management in therapeutics: when the patient becomes the last line of defense
dc.type	Editorial
dc.source.journaltitle	Pharmacoepidemiology and drug safety
dc.source.volume	11
dc.source.issue	8
dc.identifier.legacycoverpage	https://escholarship.umassmed.edu/meyers_pp/301
dc.identifier.contextkey	2396662
dc.identifier.submissionpath	meyers_pp/301
dc.contributor.department	Department of Medicine, Division of Geriatric Medicine
dc.contributor.department	Meyers Primary Care Institute
dc.source.pages	637-9